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Patients with generalized atrophic benign epidermolysis
bullosa, a usually nonlethal form of junctional epidermo-
lysis bullosa, have generalized blistering, nail dystrophy,
patchy alopecia, and dental abnormalities. Skin fragility
in most cases is due to mutations in the gene encoding
type XVII collagen (COL17A1). Recently, we reported
five Austrian families with generalized atrophic benign
epidermolysis bullosa who share the same COL17A1
mutation. Affected individuals in three families are homo-
zygous for 4003delTC, whereas those in two others are
compound heterozygotes. To determine if the occurrence
of 4003delTC in these unrelated families signifies propaga-
tion of an ancestral allele or a mutational hot spot,
haplotypes were determined for polymorphisms both
within and flanking COL17A1. Five intragenic poly-
In 1982, Hintner and Wolff described eight patients with a formof junctional epidermolysis bullosa that was generally nonlethal(Hintner and Wolff, 1982). These patients with generalizedatrophic benign epidermolysis bullosa (GABEB) shared featuresof chronic blistering with onset at birth, mucosal involvement,
alopecia, dental abnormalities, and nail dystrophy. These features had
been noted earlier in five other patients (Hashimoto et al, 1976;
Schnyder and Anton-Lamprecht, 1979), and have been seen in only
about 40 cases reported to date (Darling et al, 1997a). The rarity of
this disease makes it remarkable that Hintner and Wolff were able to
identify eight Austrian patients with GABEB in their initial report
(Hintner and Wolff, 1982). The relatively high local occurrence of
GABEB could not be attributed to close blood relationships, as the
patients were from five different families not known to be related to
each other.
The occurrence of a rare genetic disease at a high frequency within
a population can be explained by a founder effect with or without
random genetic drift, or selective advantage. Recently, support for
these different mechanisms has been provided by the identification of
causative mutations in several inherited conditions (Zlotogora, 1994).
The presence of only one causative mutation within the population,
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morphisms were chosen based on their informativeness.
One of these, not previously reported, was 2988 A or C
that introduces a new restriction site for Eco0109 I. All
the 4003delTC alleles showed the same haplotype for
these five polymorphic markers. Fourteen microsatellite
polymorphisms were selected based on their high hetero-
zygosity and their location within 10q23–q25 near
COL17A1. Three families shared microsatellite poly-
morphisms covering at most 19 cM, whereas the others
shared smaller regions consistent with cross-over events
during passage of this mutation through several genera-
tions. These results indicate that 4003delTC occurs on a
single ancestral allele. Key words: inherited blistering disease/
polymorphism/type XVII collagen. J Invest Dermatol 110:170–
173, 1998
for example, suggests that the mutation appeared in an ancestor
common to all of the individuals, the so-called founder. In contrast, if
a population with a high frequency of a rare disease is found to exhibit
multiple different mutations, this suggests that the disease in some way
gives heterozygous individuals a selective advantage for survival, as is
found for thalassemia and sickle cell anemia, which seem to protect
heterozygotes against malaria (Zlotogora, 1994). With the recent
identification of causative mutations, such studies can now be applied
to patients with GABEB. Many individuals with GABEB have been
shown to have mutations in the gene encoding type XVII collagen
(McGrath et al, 1995, 1996a, b; Darling et al, 1997b; Gatalica et al,
1997; Jonkman et al, 1997; Schumann et al, 1997; Chavanas et al,
1997), a protein associated with hemidesmosomes and anchoring
filaments in epidermal basement membrane (Masunaga et al, 1997).
Our analysis of the families originally reported by Hintner and Wolff
(1982) revealed that affected individuals in four of these five families
had a 2 bp deletion in COL17A1, 4003delTC (Darling et al, 1997b).
In addition, an individual with GABEB from a sixth Austrian family
(Grubauer et al, 1989) also shared this mutation (Darling et al, 1997b).
The occurrence of the same mutation in five Austrian GABEB families
suggests the possibility of a founder effect. Another possibility, however,
is that this deletion mutation arose independently in several individuals,
and as such represents a mutational ‘‘hot spot.’’ To determine whether
the shared occurrence of this deletion mutation in COL17A1 represents
propagation of an ancestral allele or a mutational hot spot, we established
haplotypes for the chromosome bearing the mutant allele in these
families, using both intragenic and microsatellite polymorphisms. The
results indicate that the deletion mutation occurs on a single ancestral
allele.
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Figure 1. The mutant COL17A1 alleles in five Austrian families with
generalized atrophic benign epidermolysis bullosa exhibit the same
haplotype for five intragenic polymorphisms. The pedigrees for families
A–E are shown. Symbols are encoded as follows: white, homozygous normal
individual; black, homozygous 4003delTC; white and black, heterozygous for
4003delTC. Deceased individuals are indicated by a slash, including the affected
family member (II-11) who died in infancy. The affected individuals in families
D and E are heterozygous for 4003delTC and possess distinct nonsense mutations
in COL17A1 on the paternally inherited alleles (indicated by diagonal lines).
Haplotypes for each allele are displayed below the symbols, with the 4003delTC
allele contained within a box. The deduced haplotypes for each allele of
individual I-2 in family A are shown in brackets. Individuals without a haplotype
in this figure are those from whom DNA was not available.
MATERIALS AND METHODS
Patient data Pedigrees of the five GABEB families are shown in Fig 1. The
families were not known to have any common lineage. All patients had
characteristic features of GABEB as described previously (Darling et al, 1997b).
Skin biopsies from these patients showed absent staining for type XVII collagen
in epidermal basement membrane (Pohla-Gubo et al, 1995). All affected
individuals share the 4003delTC mutation in COL17A1 (McGrath et al, 1996a;
Darling et al, 1997b). This deletion mutation has not been observed anywhere
else in the world to date.
Haplotype analysis Haplotypes were determined for polymorphisms both
within COL17A1 and flanking the gene. Five intragenic polymorphisms were
chosen based on their allele frequencies and/or demonstration of informativeness
at this locus in earlier studies of the families (Darling and Yancey, unpublished).
Four of these polymorphisms were reported previously (Gatalica et al, 1997),
including 734 T/C in exon 10, 1168 T/C in exon 14, 3009 A/G in exon 44,
and 4214 A/G in exon 52 [nucleotide numbers of COL17A1 cDNA according
to Giudice et al (1992)]. Each polymorphism can be detected by a change in a
restriction endonuclease site (BsrD I, Dde I, Msp I, and Bgl II, respectively). A
fifth polymorphism, 2988 A/C, was discovered upon generating our own
COL17A1 cDNA. This polymorphism results in a new restriction site for
Eco0109 I. The allele frequency, based on analysis of DNA from 51 unrelated
North American control subjects, is 0.86 A and 0.14 C, resulting in a value of
0.21 for the polymorphism information content. For studies of intragenic
polymorphisms, polymerase chain reaction (PCR) was used to amplify regions
of genomic DNA, using primer pairs as previously described (Gatalica et al,
1997). The PCR product was subjected to restriction endonuclease digestion
by the appropriate enzyme according to the manufacturer’s recommendations
(New England BioLabs, Beverly, MA). The digestion products were then
electrophoresed on 2% agarose gels, and bands visualized with ethidium bromide.
Microsatellite polymorphisms varying in number of nucleotide repeats were
selected from the genome database on the basis of their location within band
10q23–q25 and their position flanking COL17A1, as well as their high
heterozygosity. The selected markers included D10S608, D10S192, D10S521,
D10S1795, D10S254, D10S175, D10S534, D10S467, D10S1246, D10S597,
D10S1750, D10S1269, D10S209, and D10S214. These markers span µ42 cM
on chromosome 10q (Locus Data Base, University of Southampton, U.K.).
The order and distances of all of these markers relative to COL17A1 are not
defined at this time. We have analyzed our data based on the Locus Data Base
map of March 1996. For detection of these markers, PCR was used to amplify
these polymorphisms, using [α-33P]dCTP (Amersham, Arlington Heights, IL)
for labeling, followed by electrophoresis on 6% polyacrylamide gels (Hudson
et al, 1997). The following cycling conditions were used for PCR: 96°C for
5 min, followed by 35 cycles of 94°C for 45 s, 55°C for 45 s, and 72°C for
45 s. Three microliters of PCR product were added to 3 µl of formamide and
the mixture was heated to 96°C for 2 min and then placed on ice. Samples of
4 µl were electrophoresed on a 6% polyacrylamide gel (Gel-Mix 6, Gibco
BRL, Gaithersburg, MD) at 50 w. Gels were dried and exposed to Biomax
MR film (Kodak, Rochester, NY) overnight at –70°C. Haplotypes were
assigned independently by at least two investigators.
RESULTS AND DISCUSSION
COL17A1 polymorphisms on the mutant alleles in five GABEB
families are the same Affected individuals in families A–C are
homozygous for the deletion mutation 4003delTC, whereas those in
families D and E are compound heterozygotes. These latter patients
exhibit the 4003delTC mutation on the maternally inherited allele and
contain different nonsense mutations in COL17A1 on the paternally
inherited allele (Fig 1) (Darling et al, 1997b). Analysis of intragenic
polymorphisms revealed a common haplotype (AAABB) universally
shared on the mutant allele in all individuals (Fig 1). Individuals
homozygous for 4003delTC were homozygous for AAABB, whereas
unaffected carriers had one AAABB allele. In families B–E, all of the
normal alleles showed a haplotype distinct from the mutant allele, and
each polymorphism was informative in at least one family. In family
A, however, only the exon 52 polymorphism was informative. Also,
the grandfather in family A (individual I-2) was deduced to have the
same haplotype on both the mutant and the normal alleles. Thus
certain offspring had an AAABB haplotype on the unaffected allele
(individuals II-5, II-6, II-9, II-12, and III-3). Analysis of six additional
intragenic polymorphisms in individuals I-1, II-8, II-9, and III-2 from
family A failed to differentiate the paternal chromosomes (data not
shown). The common haplotype observed on the mutant alleles in
these families suggests that the 4003delTC mutation is not the result
of separate mutations occurring independently in different individuals,
but is the result of a one-time mutation occurring in an ancestor
common to all the families.
Polymorphisms flanking COL17A1 are shared on the mutant
alleles Microsatellite polymorphisms were examined to discriminate
the paternal haplotype of family A and further test for a shared ancestral
allele. In families A, B, and C, a common homozygous haplotype for
the mutant allele is observed in all of the affected individuals, providing
further support for propagation of an ancestral allele (Figs 2, 3). This
was also substantiated by identifying a unique haplotype for the
paternally inherited normal allele in family A, i.e., the deduced mutant
and normal alleles in individual I-2 show distinct haplotypes (Fig 2).
Also evident in family A is the suggestion that the mutant allele has
been propagated for at least six generations. Individual III-2, whose
father shares common ancestry with his mother going back several
generations, shows the same haplotype for the (paternally inherited)
mutant allele as in the maternal grandfather (I-2). This suggests that
the mutant allele was present in the distant ancestral couple, and perhaps
in earlier generations as well. It should be noted that constructing this
conserved haplotype necessitates a double recombination between
D10S1795 and adjacent markers during meiosis in the mother (II-9).
The low likelihood of a double recombination within this short region
suggests that the placement of this locus is incorrect and that it
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Figure 2. Microsatellite polymorphisms flanking COL17A1 are shared
on the mutant alleles in five GABEB families. Symbols and haplotypes are
designated as in Fig 1. The relative positions of the markers are from centromeric
at the top to distal at the bottom. The COL17A1 gene in this map is located
between D10S467 and D10S1246. –, not done. A possible double recombination
between D10S1795 and its flanking markers is shown in individual III-2 by
horizontal lines above and below the polymorphism (see text for additional
details).
actually lies centromeric to D10S521 (i.e., positioning D10S1795 above
D10S521 in Fig 2). By ordering the markers in this manner, the
observed haplotype results from a single recombination. Such a change
in ordering would not be unexpected as the ordering of these markers
is in evolution. In fact, a recent map moves D10S1795 centromeric
to the other markers but just distal to D10S521 (Locus Data Base
map of 9/96). Another possible explanation for the apparent double
recombination is that the ‘‘3’’ allele at D10S1795 in III-2 represents a
mutation in the microsatellite repeat polymorphic site. Such mutations
have been estimated to occur for human microsatellites at a rate of 10–
3–10–5 per locus per generation (Schug et al, 1997).
In families D and E, several of the microsatellite polymorphisms are
the same as in families A–C. Other markers are distinct from families
A-C but shared between families D and E, as indicated by the box
surrounding the markers from D10S521 to D10S534 (Fig 3). This
suggests that the individuals in families D and E are more closely
related to each other than to families A–C, and that a cross-over event
took place during the passage of the mutant allele through several
generations. Considering the present uncertainty in the relative positions
of these markers, some of the polymorphisms below the boundary of
the conserved region in families D and E may actually lie closer to the
COL17A1 gene than indicated. D10S1269, for example, shows the
Figure 3. A single ancestral COL17A1 allele is evident for the intragenic
and flanking polymorphisms in affected individuals from families A–
E. This figure compiles the data from Figs 1 and 2 for the specified affected
individuals from all five GABEB families. In addition, four microsatellite
polymorphisms more distal from COL17A1 are included. The haplotypes for
each mutant allele are shown in vertical columns. Regions of a common
haplotype are enclosed within shaded boxes. A shared haplotype was not
observed for the more distal polymorphisms D10S608, D10S192, D10S209,
and D10S214, and these polymorphisms were not assigned to a specific allele
as indicated by the commas. The ordering of the markers is again according to
the Locus Data Base map of March 1996. The approximate distances between
microsatellite markers are also shown, using D10S597 as a reference point.
Distances are reported in cM (Dib et al, 1996) as well as in Mb for the four
microsatellite markers physically mapped at this time (Stanford Human Genome
Center G3 Radiation hybrid map, May 12, 1997).
same haplotype in all five families and thus may be closer to COL17A1
than D10S1246, which shows a different haplotype in the affected
individual in family E. Regardless of the exact order or specific distances
among these markers in the region of COL17A1, our data indicate a
single ancestral allele for the deletion mutation in this population. The
lack of physical mapping data precludes an estimate of the size of the
conserved region flanking COL17A1, and thus it is not possible at this
time to determine the number of generations since the original
mutation was introduced into the population.
A single ancestral allele for a deletion mutation in GABEB In
this report we show that a mutation in COL17A1, shared by five
Austrian families with GABEB, exhibits a common haplotype for
polymorphisms within and near COL17A1, suggesting a founder effect.
In other inherited blistering diseases, evidence for propagation of
ancestral alleles has been presented for recurrent mutations in other
genes. These include three recurrent mutations in the type VII collagen
gene in some Italian and British patients with recessive dystrophic
epidermolysis bullosa (Christiano et al, 1996; Mellerio et al, 1997), and
a recurrent mutation in the LAMA3 gene in some Pakistani patients
with Herlitz junctional epidermolysis bullosa (McGrath et al, 1996c).
In the current study, affected individuals in three of the GABEB
families are homozygous for the ancestral allele. In two other families,
the affected individuals are compound heterozygotes, with the second
allele containing distinct mutations that are currently unique to these
families. This is consistent with the propensity of a founder mutation
to allow, in recessively inherited diseases, the phenotypic expression
of rare mutations. These results suggest that patients in Austria with
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an undiagnosed form of junctional epidermolysis bullosa should be
screened for the presence or absence of the 4003delTC mutation as
part of their initial genetic evaluation. This can be done by PCR
amplification of the mutant exon of COL17A1 followed by restriction
endonuclease digestion with Nla III (Darling et al, 1997b). A similar
screening strategy has been proposed for populations exhibiting a
common mutant allele in other inherited skin diseases (De Laurenzi
et al, 1997; Mellerio et al, 1997).
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